Back
ADC Therapeutics SA 10K Form
Sell
28
ADCT
ADC Therapeutics SA
Last Price:
$3.79
Seasonality Move:
11.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADCT News And Ratings
See the #1 stock for the next 7 days that we like better than ADCT
ADCT Financial Statistics
Sales & Book Value
| Annual Sales: | $81.4M |
|---|---|
| Cash Flow: | $-31M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.48 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.20090 |
|---|---|
| Net Income (TTM): | $-142.6M |
| Gross Margin: | $73.7M |
| Return on Equity: | 0% |
| Return on Assets: | -46.62% |
ADC Therapeutics SA Earnings Forecast
Key ADC Therapeutics SA Financial Ratios
-
The Gross Profit Margin over the past 9 years for ADCT is 90.57%.
-
The Selling, General & Administrative Expenses for ADCT have been equal to 98.25% of Gross Profit Margin.
-
The Research & Development expenses have been 127.84% of Revenue.
-
The Net Earning history of ADCT is -175.31% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 5 years.
ADC Therapeutics SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADCT |
| CUSIP: | H0036K |
| Website: | adctherapeutics.com |
Debt
| Debt-to-Equity Ratio: | -2.37 |
|---|---|
| Current Ratio: | 4.37 |
| Quick Ratio: | 4.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ADCT Technical Analysis vs Fundamental Analysis
Sell
28
ADC Therapeutics SA (ADCT)
is a Sell
Is ADC Therapeutics SA a Buy or a Sell?
-
ADC Therapeutics SA stock is rated a SellThe current ADC Therapeutics SA [ADCT] share price is $3.78. The Score for ADCT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.